Clinical Trial Update: Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

This is a Phase 4 extension study evaluating the safety and efficacy of enteric-coated mycophenolate sodium in kidney transplant recipients, which has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED